December 24, 2024 06:51 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Allu Arjun quizzed by police in Pushpa 2 stampede case | Wanted Indian drug smuggler killed in the US | Congress leader files complaint against Allu Arjun for 'insulting police' in Pushpa 2: The Rule | Ahead of Jaishankar's US visit, foreign secretary Vikram Misri meets top US diplomats | India refrains from commenting on extradition request for ousted Bengladeshi PM Sheikh Hasina | I don't blame Allu Arjun, ready to withdraw case: Pushpa 2 stampede victim's husband | Indian New Wave Cinema Architect Shyam Benegal dies at age 90 | Cylinder blast at a temple in Karnataka's Hubbali injures nine people | Kuwait PM personally sees off Modi at airport as Indian premier concludes two-day trip | Three pro-Khalistani terrorists, who attacked a police outpost in Gurdaspur, killed in an encounter

Sanofi collaborates with Dr. Reddy’s Labs to promote and distribute its vaccine brands in India

Mar 28, 2024, at 05:26 am

New Delhi: Hyderabad-based pharmaceutical major Dr. Reddy’s Laboratories Limited (DRL) on Wednesday announced an exclusive partnership with Sanofi Healthcare India Private Limited to promote and distribute Sanofi’s vaccine brands across the country.

Sanofi partners with Cipla to distribute and promote its Central Nervous System product range in India

Mar 27, 2024, at 06:16 am

Mumbai: Pharma companies Sanofi India and Cipla Limited on Tuesday announced an exclusive partnership for the distribution and promotion of Sanofi India’s Central Nervous System (CNS) product range in India.

Sanofi appoints Nikhilesh Kalra to lead consumer healthcare business for India, South Asia

Apr 13, 2017, at 03:45 am

Kolkata/Mumbai, Apr 12 (IBNS): Sanofi announced the appointment of Nikhilesh Kalra as the General Manager of its Consumer Healthcare (CHC) business in India and South Asia.

Sanofi, Regeneron announce positive Dupilumab Topline results from two phase 3 trials

Apr 02, 2016, at 04:39 am

Kolkata/Paris, Apr 1 (IBNS) Sanofi and Regeneron Pharmaceuticals, Inc. announced that two placebo-controlled Phase 3 studies evaluating investigation dupilumab in adult patients with inadequately controlled moderate-to-severe atopic dermatitis (AD) met their primary endpoints.

Sanofi appoints Suresh Kumar to Executive Committee

May 27, 2015, at 11:43 pm

Paris, May 27 (IBNS): Sanofi on Wednesday announced the appointment of Suresh Kumar as a new member of the Executive Committee, effective June 1, 2015.